Table 1 Clinical characteristics and treatment of stage III GC patients
Variables | Number | Percent |
|---|---|---|
Total | 97 | |
Gender | ||
Male | 61 | 63% |
Female | 36 | 37% |
Age | ||
≥65 | 51 | 53% |
<65 | 46 | 47% |
Tumor location | ||
U | 19 | 20% |
M | 28 | 29% |
L | 32 | 33% |
Whole | 18 | 19% |
Tumor major axis(mm) | ||
≥90 | 33 | 34% |
<90 | 64 | 66% |
T-stage | ||
T2 / T3 | 27 | 28% |
T4 | 70 | 72% |
N-stage | ||
N1/ N2 | 47 | 48% |
N3 | 50 | 52% |
Histopathological type | ||
Differentiated | 31 | 32% |
Undifferentiated | 66 | 68% |
Venous invasion | ||
Present | 49 | 51% |
Absent | 48 | 49% |
Lymphatic invasion | ||
Present | 87 | 90% |
Absent | 10 | 10% |
Surgical procedure | ||
Total gastrectomy | 53 | 55% |
Distal gastrectomy | 44 | 45% |